SCHEMBL9018397

SCHEMBL9018397

CCCC(CCC)OC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCOC)cc2)cn1

nearest known ligand 0.41

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.41
EPHX2 P34913 2/20 0.39
GABRA5 P31644 2/20 0.39
EGFR P00533 2/20 0.39
KMT2A Q03164 4/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
BRAF P15056 1/20 0.36
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9018299 0.93 EPHX2 (0.38) P4HTMEPHX2EGFRKMT2AHPGD
SCHEMBL9018422 0.92 CA2 (0.41) P4HTMEPHX2EGFRKMT2AKDM4E
SCHEMBL9018307 0.91 EGFR (0.41) P4HTMEPHX2GABRA5EGFR
SCHEMBL9018310 0.91 RAB9A (0.48) P4HTMKMT2AHPGDALDH1A1MEN1
SCHEMBL9018082 0.90 CA2 (0.47) P4HTMEPHX2EGFRKMT2AALDH1A1
SCHEMBL9018283 0.90 KMT2A (0.43) EPHX2KMT2AHPGDKDM4EALDH1A1
SCHEMBL9018202 0.89 P4HTM (0.43) P4HTMEPHX2GABRA5EGFRKMT2A
SCHEMBL9018513 0.89 NPC1 (0.47) P4HTMKMT2AMEN1
SCHEMBL9018090 0.88 KMT2A (0.50) P4HTMKMT2AALDH1A1MEN1
SCHEMBL9018091 0.88 MEN1 (0.44) P4HTMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0590520-B1 Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments HOECHST AG (DE) 1996-06-12 EP disclosed
EP-0590520-A1 Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1994-04-06 EP disclosed